HIGHLIGHTS
- who: Kang Zou and collaborators from the Department of Critical Care Medicine, Medical Center of Anesthesiology and Pain, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, China have published the paper: Upregulation of NDUFAF2 in Lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker, in the Journal: Computational and Mathematical Methods in Medicine 0.50 of 17/01/2023
- what: Our research revealed that NDUFAF2 was predominantly expressed in LUAD, and its expression played a critical role in the diagnosis and prognosis of LUAD.
- how: The results showed that the expression . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.